SCHEMBL4993153

SCHEMBL4993153

Nc1ncnc2c1CCN(Cc1cccc(Oc3cccc(C(F)(F)F)c3)c1)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.46
BRS3 P32247 1/20 0.43
MAPT P10636 1/20 0.42
LTA4H P09960 1/20 0.42
ROCK2 O75116 1/20 0.42
KDR P35968 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
PGGT1B P53609 1/20 0.40
LIMK1 P53667 1/20 0.40
RBP4 P02753 1/20 0.40
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4985989 0.91 KDM4E (0.50) FAAHBRS3KDM4EALDH1A1GAA
SCHEMBL4986729 0.88 ALDH1A1 (0.49) FAAHKDM4EALDH1A1GAALMNA
SCHEMBL4993434 0.86 GPR52 (0.44) LIMK1GPR52
SCHEMBL4985030 0.83 SIGMAR1 (0.50) MAPTKDM4EALDH1A1GAAHTR2C
SCHEMBL4985486 0.82 DRD2 (0.43) FAAHMAPTROCK2KDM4EALDH1A1
SCHEMBL4983036 0.80 RPS6KB1 (0.49) KDM4EALDH1A1LIMK1
SCHEMBL4988843 0.79 ALDH1A1 (0.47) ALDH1A1KMT2ALIMK1
SCHEMBL4989378 0.78 LIMK1 (0.51) FAAHMAPTKDM4EALDH1A1GAA
SCHEMBL4993341 0.78 MEN1 (0.51) MAPTKDM4EALDH1A1GAAHTT
SCHEMBL14272546 0.78 FAAH (0.46) FAAHROCK2KDRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 FAAH 494/4885BRS3 380/4885MAPT 4477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.